CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,818,000 | -20.2% | 948,389 | -36.2% | 26.68% | +185.5% |
| Q2 2021 | $17,323,000 | -44.3% | 1,486,986 | -41.7% | 9.34% | -18.4% |
| Q1 2021 | $31,098,000 | +29.8% | 2,549,031 | +33.1% | 11.45% | +100.8% |
| Q4 2020 | $23,959,000 | +10.7% | 1,915,219 | +33.2% | 5.70% | -48.0% |
| Q3 2020 | $21,634,000 | +33.7% | 1,437,445 | +117.8% | 10.97% | +4.7% |
| Q2 2020 | $16,176,000 | +39.0% | 659,987 | -19.5% | 10.48% | -16.6% |
| Q1 2020 | $11,636,000 | +157.2% | 820,000 | +187.7% | 12.56% | +416.9% |
| Q4 2019 | $4,524,000 | – | 285,000 | – | 2.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |